Demographic Features of the Control and Treatment Groups of Patients Who Underwent Total Hip Arthroplasty*
| Demographic feature | Control | TCP |
|---|---|---|
| Gender, no. (and %) | ||
| Male, n = 41 | 23 (56) | 18 (44) |
| Female, n = 51 | 23 (45) | 28 (55) |
| Age, yr | ||
| Mean (and SD) | 59.1 (9.7) | 60.5 (8.5) |
| Range | 37–74 | 36–73 |
| Weight, kg | ||
| Mean (and SD) | 84.1 (19.8) | 81.5 (14.2) |
| Range | 40–138 | 53–104 |
| Body mass index | ||
| Mean (and SD) | 29.7 (6.2) | 28.3 (4.6) |
| Range | 15.6–41.6 | 21.8–38.4 |
| Diagnosis | ||
| Osteoarthritis | 35 | 36 |
| Post-traumatic arthritis | 3 | 0 |
| Rheumatoid arthritis | 4 | 4 |
| Psoriatic arthritis | 1 | 0 |
| Avascular necrosis | 2 | 3 |
| Epiphyseal defect | 1 | 1 |
| Diastrophic variant | 0 | 1 |
| Ankylosing spondylitis | 0 | 1 |
↵* Control = patients receiving a non-coated femoral implant, treatment = patients receiving a tricalcium phosphate (TCP) femoral implant.